ERIC CHEN, MD
Ophthalmology Physician · HOUSTON, TX
Individual Active NPI 1578521779
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 933 | 22,383 | $12,125,042 | $3,746,824 | $2,954,102 |
| 2023 | 989 | 17,992 | $12,032,064 | $3,837,486 | $3,024,904 |
| 2022 | 992 | 11,157 | $7,592,931 | $3,791,474 | $2,982,399 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 8,400 | $34 | $27 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 3,405 | $147 | $117 |
| J0177 | Injection, aflibercept hd, 1 mg | 2,144 | $332 | $265 |
| 92134 | Imaging of retina | 2,009 | $42 | $31 |
| 92014 | Established patient complete exam of visual system | 1,369 | $129 | $92 |
| 67028 | Injection of drug into eye | 1,287 | $136 | $104 |
| J0178 | Injection, aflibercept, 1 mg | 1,252 | $819 | $652 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 931 | $239 | $189 |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 425 | $167 | $133 |
| J2778 | Injection, ranibizumab, 0.1 mg | 287 | $147 | $117 |
| 92250 | Photography of the retina | 168 | $37 | $28 |
| J3590 | Unclassified biologics | 121 | $2,661 | $2,116 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | M6563 | TX |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | M6563 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1295817609
- NPI 1023436896
- NPI 1588815468
- NPI 1437254976
- NPI 1477290617
- NPI 1619491941
- NPI 1336405463
- NPI 1811519358
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.